Finnish biotechnology company Biohit Oyj (HEL:BIOBV) on Friday introduced the Biohit FAEX Sample System, a new stool sample collection and handling solution designed for seamless integration into diagnostic workflows.
According to Biohit, the system enhances precision, efficiency and flexibility for both patients and laboratories.
The Biohit FAEX Sample System functions as both a standard test tube and a dropper tube, ensuring accurate and reproducible sample dispensing for ELISAs, chemiluminescence assays, lateral flow tests and proprietary diagnostic kits. A precision-engineered collection stick enables consistent sample collection, while a screw-tight cap with leak-proof threads ensures safe handling, transport and storage.
CE-marked and compliant with Regulation (EU) 2017/746 for In Vitro Diagnostic Devices, the system meets high regulatory standards. It can be used as a standalone component or as part of a diagnostic kit, offering a practical and reliable solution for stool sample processing.
Bioretec Ltd secures CE mark approval for RemeOs Trauma Screw portfolio
Biohit launches FAEX Sample System for stool sample collection
Renalys Pharma completes patient enrolment for Phase III clinical trial of sparsentan
Innocan Pharma's BI Sky Global completes industry standard safety test
ColdVentures partners with Medco Sports Medicine to combat heat stroke
Median Technologies secures funding for eyonis Lung Cancer Screening software
MicroAire Surgical Instruments acquires NEOSYAD
UCB launches 320 mg/2 mL single-injection administration option for BIMZELX (bimekizumab-bkzx) in US
Concept Medical reports first patient enrolled in MagicTouch SCB trial in peripheral artery disease
Creo Medical Group plc launches robotic-guided lung ablation procedures in the UK